Early Rehabilitation Using Head Impulse Test for Acute Vestibular Deficit
Launched by HOSPICES CIVILS DE LYON · Oct 24, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how early rehabilitation can help patients recover from a specific type of balance problem known as acute unilateral vestibular deficit (AUVD). This condition often occurs after surgery to remove a tumor on the balance nerve, called a vestibular schwannoma. The researchers want to find out if practicing certain eye movements soon after surgery can help patients learn to regain their balance and improve their vision. They will use a test called the Head Impulse Test to measure how well the eyes move in response to head movements, which is important for keeping our vision clear when we move.
To be eligible for this trial, participants must be adults aged 65 to 74 who have a unilateral vestibular schwannoma and are scheduled for surgery. They should have certain eye movement measurements that indicate a vestibular problem. Before joining the study, participants will receive all necessary information about the trial at least 15 days before their surgery and will provide consent the day before. If they decide to participate, they can expect to work with physiotherapists during their hospital stay to help with their recovery. It's important to note that some people will not be eligible, such as those with other eye or balance issues, certain medical conditions, or those who have had specific treatments like radiation before surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with unilateral vestibular schwannoma and programmed surgery
- * vestibulo-ocular reflex gain :
- • on pathological side \> 0.50
- • on healthy side \> 0.80
- • all information's concerning the study given more than 15 days before surgery and consent collected the day before surgery
- Exclusion Criteria:
- • Radiotherapy treatment prior to surgery.
- • Resumption of surgery
- • Presence of bilateral vestibular schwannomas
- • Normal or Corrected to normal distance visual acuity \< 5/10
- • Presence of other aetiologies that may explain the ataxic syndrome and/or oscillopsias
- • Oculomotor paralysis, ocular instability in primary position
- • Use of medications that compromise eye movement (psychotropic drugs)
- • Cervical spinal pathology with instability (contraindication for vHIT)
- • Cochlear implantation
- • Non-stabilized medical condition
- • Pregnant women. This exclusion criterion will be investigated by questioning the patient.
- • Patient under guardianship
- • Patient not affiliated to a social security scheme
- • Patient participating any other interventional study
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bron, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported